viewEuroLife Brands

Cannvas MedTech says planned expansion into Europe is on track; plans to raise C$2M

With its expansion into Germany underway, the firm is now turning attention towards the UK, among other emerging markets

Cannabis plant
Cannvas Medtech is a cannabis education and analytics firm

Cannvas MedTech Inc (CSE: MTEC) (OTCMKTS:CANVF) the  cannabis education and analytics  firm, said its planned expansion into Europe is on track as it also announced plans to raise C$2 million via a non-brokered private placing.

With its expansion into Germany underway, the  firm says it's turning attention towards the the UK as well as other emerging cannabis markets across the EU.

Exploring locations

It says it is exploring ideal locations to potentially set up operations in one or more central European locations, pending the outcome of ongoing high-level conversations with potential EU partner organizations.

"Brightfield Group projects Europe's legal medical cannabis sales to reach nearly $8 billion by 2023, while London-based Prohibition Partners forecast the European medicinal cannabis market to be worth US$65.6 billion by 2028," the firm said in a wide-ranging statement.

Meanwhile, Prohibition Partners believes the number of patients in the three biggest European markets - Germany, Italy, and the Netherlands - will rise from 130,000 in 2018 to 225,000 in 2019, with the cannabis industry in those three countries alone to be worth U$20.4 billion by 2028,  Cannvas highlighted.

Global spending on legal cannabis is forecast to be US$40.8 billion in 2024, nearly triple the US$14.9 billion estimated to be spent this year, according to Arcview Market Research and cannabis industry analysis firm BDS Analytics.

Refining technologies

With over 350 original and evidence-based educational articles encompassing all aspects of cannabis, Cannvas is refining the technologies that power its learning platform to better serve European audiences’ content.

Using its learning platform called Cannvas.Me, the company plans on contributing to the cannabis knowledge landscape across Europe.

Also, in today's statement, Cannvas told investors it plans to raise up to C$2 million through a private placement of up to 10 million units at C$0.20 a throw.

Each unit consists of one share and one transferable warrant exercisable at C$0.30 for two years. The proceeds will be used for developing the technology platforms and general working capital.

Contact the author at [email protected]

Quick facts: EuroLife Brands

Price: 0.175 CAD

Market: CSE
Market Cap: $6.69 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of EuroLife Brands named herein, including the promotion by the Company of EuroLife Brands in any Content on the Site, the Company receives from...


Buds & Duds: Cannabis stocks reverse; Nabis Holdings jumps after securing...

The North American Marijuana Index, lost 1.5% to 136 points. The OTCQX Cannabis Index dipped 1.4% to 504 points. Buds today were Nabis Holdings Inc (CSE:NAB) (OTCMKTS:NABIF), EuroLife Brands Inc (CSE:EURO) (OTCMKTS:CANVF). Duds were HEXO Corp (TSE:HEXO)...

on 10/16/2019

2 min read